Mitochondrial cardiomyopathy is associated with deleterious remodelling of cardiomyocyte Ca 2+ signalling that is partly due to the suppressed expression of the sarcoplasmic reticulum (SR) Ca 2+ buffer calsequestrin (CASQ2). This study was aimed at determining whether CASQ2 downregulation is directly caused by impaired mitochondrial function.
Introduction
Mitochondrial dysfunction poses severe challenges to cells that are heavily energy-dependent, such as cardiomyocytes, and it has been shown to underlie pathological conditions including hypertrophic cardiomyopathy, arrhythmias, doxorubicin-induced cardiomyopathy, 1, 2 and sudden cardiac death (for reviews, see references 3, 4) . It is known that impaired oxidative phosphorylation (OXPHOS) contributes to disease progression via energy depletion, oxidative stress, and regulation of apoptosis. 5 While the mechanisms linking mitochondrial dysfunction and cardiac performance are subjects of ongoing investigation, animal models have shed some light on disturbances in cardiomyocyte function. Significant changes in cardiomyocyte Ca 2+ handling were found in a mouse model of mitochondrial cardiomyopathy with cardiac-specific knockout of mitochondrial transcription factor A; Ca 2+ handling was impaired possibly due to changes in sarcolemmal Ca 2+ buffering capacity, with marked downregulation of the sarcoplasmic reticulum (SR) Ca 2+ buffer calsequestrin 2 (CASQ2).
6
CASQ2 is normally expressed at constant levels throughout life 7 and not only acts as an SR Ca 2+ sensor, but also regulates SR Ca 2+ release via interactions with triadin, junctin, and the ryanodine receptor. 8 -10 Dysregulation of CASQ2 expression leads to altered Ca 2+ release and contractile dysfunction, is involved in the pathogenesis of doxorubicin-induced cardiomyopathy, 11, 12 and contributes to the development of arrhythmias and sudden cardiac death in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). 13 At the cellular level, impaired Ca 2+ handling due to mitochondrial dysfunction would have serious consequences for cardiac cells, as Ca 2+ signals regulate cell contractions as well as a myriad of cell signalling cascades involved in metabolism and gene expression. 14, 15 The importance of mitochondria in maintaining cardiac cell function is well known, but what is less understood is how mitochondrial dysfunction contributes to the pathological changes of cardiomyocytes, which later lead to heart disease. Mitochondrial cardiomyopathy is associated with progressive changes in the morphology of mitochondria, an adaptive, transcriptional switch from oxidative to anaerobic metabolism 16 
Methods

Cell isolation and culturing
All protocols conform to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85 -23, revised 1996) and were approved by the Animal Use and Care Committee of the University of Oulu. Rat neonatal ventricular cardiomyocytes were isolated 1 -2 days after birth as described previously. 17 Briefly, ventricles were excised, cut into small pieces, and incubated for 1 h in a solution containing (in mM): 100 NaCl, 10 KCl, 1.2 KH 2 PO 4 , 4.0 MgSO 4 , 50 taurine, 20 glucose, 10 HEPES, 2 mg/mL collagenase type II (Worthington, Lakewood, NJ, USA), 2 mg/mL pancreatin (P-3292, Sigma, St Louis, MO, USA), and 1% penicillin -streptomycin. After incubation, the detached cells were collected in 15 mL Falcon tubes and centrifuged for 5 min at 160 g. The supernatant and the top layer of the pellet containing damaged cells were discarded. For mRNA and protein measurements, the isolated cardiomyocytes were plated on 35 mm fibronectin-coated plastic dishes, and for confocal imaging, on laminin-coated, glass-bottom Petri dishes as described previously. 18 The cells were cultured to reach confluence in Dulbecco's modified Eagle's medium (DMEM) containing 10% FBS and 1% penicillin -streptomycin. Cells were cultured 48 h before pharmacological agents were applied and then cultured for another 48 h. FCCP, DEVD-CHO, SB203580, pifithrin-a, NAC were from Sigma.
Ca 21 and ROS imaging
Ca 2+ signals were measured with a confocal microscope as described previously. 18 Briefly, cells were loaded in DMEM + 1 mM probenecid solution for 1 h at 378C with fluo-4-AM-ester (10 mM, dissolved in pluronic DMSO, Molecular Probes, Eugene, OR, USA). The cells were incubated at room temperature (20 -228C) at least 30 min for the dye to de-esterify. To measure Ca 2+ signals, the culture dishes were placed in a custom-made perfusion system built into an Olympus Fluoview 1000 confocal inverted microscope. Cells were maintained at a 32 -358C by continuous superfusion with pre-heated DMEM + Glutamax I (Gibco, Carlsbad, CA, USA) culturing medium (pH 7.4, bubbled with 95% O 2 /5% CO 2 ). For Ca 2+ imaging, fluo-loaded myocytes were excited at 488 nm, and the emitted light was collected with a spectral detector from 520 to 620 nm through a ×20 or ×60 objective lens. When electrically excited, the cells were paced with 1 ms voltage pulses at 50% over the excitation threshold through two platinum wires located one on each side of the Petri dish. Cells were line-scanned at 400 -600 Hz, depending on the length of the scanning line, with a fixed pixel time of 10 ms with the ×20 objective and 2 ms with the ×60 objective. To estimate SR Ca stores, 10 mM of caffeine was applied rapidly (,2 s) on fluo-loaded myocytes. In order to equalize the SR storing conditions, the cells were paced at 0.5 Hz, and pacing was stopped 3 s before the caffeine was applied. Fluo-fluorescence intensity is expressed as an F/F 0 ratio, where F is the background-subtracted fluorescence intensity and F 0 is the background-subtracted minimum fluorescence value measured from each cell at rest. Ca 2+ sparks were analysed by SparkMaster 19 as described previously. 20 Superoxide production was measured using the indicator MitoSOX Red (Molecular Probes) according to the manufacturer's instructions. Briefly, cells were loaded with 5 mM MitoSOX reagent working solution and incubated for 10 min at 378C. During measurements, culture dishes were perfused with warm, buffered DMEM with or without FCCP and NAC. Confocal images were taken at 1024 × 1024 pixels with a ×40 oil objective, with a scanning rate of 10 ms per pixel. MitoSOX was excited at 515 nm, and emitted light was measured from 520 -620 nm. Images were analysed using ImageJ.
RNA isolation and quantitative real-time PCR
Total RNA from cell cultures was isolated using the GenElute Mammalian Total RNA Miniprep Kit (Sigma). cDNA was synthesized using the First Strand cDNA Synthesis Kit (MBI Fermentas), and quantitative PCR (qPCR) reactions were performed with the ABI 7700 Sequence Detection System (Applied Biosystems, USA) using TaqMan chemistry. The mouse calsequestrin 2 (CASQ2, BC072547) primers were 5
′ -AAGGAGCA TCAAAGACCCACC-3 ′ and 5 ′ -TCGTCTTCCCATGTTTCAAACA-3 ′ , and the fluorogenic probe was 5 ′ -Fam-CGTCGCTTGCGCCCAG AGG-Tamra-3
′ . The results were normalized to 18S rRNA quantified from the same samples using the forward and reverse primers 5 ′ -TGGTTGCAAAGCTGAAACTTAAAG-30 and 5 ′ -AGTCAAATTAAG CCGCAGGC-3 ′ and the fluorogenic probe 5 ′ -Vic-CCTGGTGGTGC CCTTCCGTCA-Tamra-3 ′ .
Western blotting
Cardiomyocytes were prepared from 2-to 4-day-old rats. Cells were plated on fibronectin-coated six-well plates at a density of 1 × 10 5 cells/cm 2 . Cells were cultured in DMEM (Invitrogen) containing 10% FPS and 1% penicillinstreptomycin for 48 h. On the third and fourth day, 1 mM FCCP with or without 1 mM NAC was added to the culture medium. After 48 h of culture with FCCP +NAC, myocytes were lysed in buffer containing (in mM): 20 Tris-HCl (pH 7.5), 150 NaCl, 1 ethylenediaminetetracetic acid, 1 ethylene glycol-bis(b-amino ethylether) tetra-acetic acid, 2.5 sodium pyrophosphate, 1 b-glycerophosphate, 1 Na 3 VO 4 , 2 benzamide, 1 phenylmethylsulfonyl fluoride, 50 NaF, 2 dithiothreitol, 1% Triton, 10 mg/mL leupeptin, 10 mg/mL pepstatin, and 10 mg/mL aprotinin. Samples were sonicated and centrifuged. The crude protein fraction was collected, and total protein concentration was measured with the Bio-Rad Protein Assay Kit II (Bio-Rad).
For western blot analysis, 20 mg of protein was used. Samples were electrophoresed on an 8% SDS -polyacrylamide gel and transferred to a nitrocellulose membrane (0.2 mm, Bio-Rad Laboratories). The membrane was blocked in 5% non-fat milk and incubated with calsequestrin 2 (PA1-913, Thermo Scientific) or GAPDH (Cell Signaling 2118) primary antibody. After incubation with horseradish peroxidase-linked secondary antibody, blots were visualized with the ECL Plus Detection Kit (GE Healthcare) using a Typhoon 9400 scanner (GE Healthcare). Protein expression was quantified with ImageQuant TL 7.0 software (GE Healthcare). Figure 2B-D) .
Statistics and data analysis
3.3. CASQ2 downregulation by FCCP is unaffected by caspase 3, p38, and p53 inhibitors
Under conditions of cell stress, numerous signalling cascades can be initiated that lead to the remodelling of cardiomyocyte gene expression and metabolism, and possibly even apoptosis. 23 Responses to mitochondrial stress, in particular, are known to involve, e.g. caspases, 24 protein kinases, 23 and transcription factor p53. 25 The effect of these pathways on cardiac-specific gene transcription in response to FCCP-induced mitochondrial stress was studied using inhibitors of caspase 3 (100 mM DEVD-CHO), p38 (10 mM sb203580), and p53 (2 mM pifithrin-a). Inhibitors were used at concentrations shown to be effective but not toxic in cultured cells in previous studies. 26 -28 Cells were cultured in the presence of 1 mM FCCP with and without inhibitor for 48 h, and CASQ2 mRNA was quantified by qPCR. The FCCP-induced repression of CASQ2 gene expression was unaffected by these inhibitors (Figure 3) , suggesting that CASQ2 downregulation is not a direct consequence of the activation of these cascades.
NAC counters the effect of FCCP on Ca 21 handling and gene expression
Mitochondrial uncouplers are known to affect mitochondrial ROS production, and elevated ROS levels are involved in various signalling cascades that alter gene expression. Therefore, the effect of FCCP on ROS production in cultured neonatal cardiomyocytes as well as the potential effect of ROS on the observed functional and gene expression changes in FCCP-treated cardiomyocytes was studied. ROS production in cultured cardiomyocytes was monitored by confocal microscopy using the superoxide indicator MitoSOX red (Molecular Probes) following exposure to FCCP and the reactive oxygen/ nitrogen species scavenger NAC. There was an 41.5% increase in superoxide levels during a 40 min perfusion with 1 mM FCCP, followed by a rapid decrease in fluorescence following the addition of 1 mM NAC ( Figure 4A and B) . Superoxide levels fell 25% after 8 min co-perfusion of FCCP and NAC ( Figure 4B) , and returned to control levels 12 min after the addition of NAC. Next we studied whether FCCP-induced downregulation of CASQ2 could be similarly reversed by NAC. Co-exposure of 1 mM FCCP + 1 mM NAC for 48 h led to a partial rescue of CASQ2 mRNA expression ( Figure 4C) . NAC attenuated the decrease in CASQ2 expression caused by FCCP alone by 50% (FCCP: 0.30 + 0.049 vs. FCCP + NAC: 0.59 + 0.027, fold changes from control, n ¼ 6). Ca 2+ transients of cultured cells were monitored following exposure to 1 mM FCCP + 1 mM NAC for 48 h; during measurements, cells were perfused without FCCP or NAC. As before, there were significant decreases in the time to peak and decay of Ca 2+ transients of cells exposed to FCCP compared with controls (P , 0.001, n ¼ 50). Cells exposed to both FCCP and NAC, Figure 1 Mitochondrial stress induces CASQ2 downregulation.
Forty-eight hour exposure to increasing FCCP concentrations causes concentration-dependent downregulation of CASQ2 mRNA expression. Values were standardized with 18S rRNA quantified from the same samples (n ¼ 6). **P , 0.01; ***P , 0.001.
Mitochondrial uncoupling downregulates calsequestrin expression however, displayed Ca 2+ transients similar to controls ( Figure 4D-F ).
The differences between the time to peak and decay of FCCP vs. FCCP + NAC Ca 2+ transients were significant (P , 0.001, n ¼ 50). Figure 5A and B). Figure 5B ]. In parallel, CASQ2 protein levels were also greater in cells co-exposed to FCCP and NAC (FCCP: 0.70 + 0.05 vs. FCCP + NAC: 0.90 + 0.12, fold changes from control, n ¼ 6; Figure 5C ). Figure 6A ). Supporting this, analysis of Ca 2+ sparks revealed significant decreases in the amplitude and duration (FDHM, full-duration-at-half-maximum) of sparks from FCCP-treated cells. Co-exposure of cells to FCCP and NAC restored spark characteristics to near control levels, indicating that NAC fully restores the functional SR in FCCP-treated cardiomyocytes ( Figure 6A and B).
NAC restores the FCCP-depressed SR Ca stores
Discussion
Mitochondrial cardiomyopathy is a progressive syndrome induced by defective OXPHOS involving deleterious metabolical, morphological, and functional changes of the heart. 34 Moreover, we demonstrate that FCCP increases the production of ROS and that the effects of FCCP on CASQ2 expression, 31, 32 ; therefore, these changes are significant, as they imply that mitochondrial uncoupling directly affects the elementary mechanisms of Ca 2+ release. It is known that insufficient levels of CASQ2 have a serious impact on Ca 2+ release and can lead to contractile dysfunction and arrhythmias, as in the case of induced cardiomyopathy 11, 12 and CPVT. 13 Even a modest 25% reduction in CASQ2 has been shown to increase SR Ca 2+ leak and increase the susceptibility of heterozygous CASQ2 +/2 mutant cardiomyocytes to stress-induced ventricular tachycardia. 35 Apart from being one of the genes altered in mitochondrial cardiomyopathy and doxorubicin-induced cardiotoxicity, very little is known about the transcriptional regulation of CASQ2. It has been reported that cardiac expression of CASQ2 requires the common cardiac transcription factors MEF-2 and SRF, 36 and overexpression of Egr-1 leads to CASQ2 repression, 37 but the specific mechanisms regulating CASQ2 expression are not well understood. Although we showed here that mitochondrial uncoupling downregulates CASQ2 expression, we also showed that the inhibition of common apoptotic pathways (caspase 3, p38, and p53) had no effect on CASQ2 downregulation. However, ROS scavenger NAC was found to reverse the effects of FCCP on CASQ2 expression and Ca 2+ signalling. Although the entire cascade between FCCP-induced ROS production and transcriptional downregulation of the nuclear CASQ2 gene was not determined in this study, an increasing number of studies have shown that ROS not only have direct effects on proteins, but are also key players in cell signalling cascades leading to transcriptional regulation (for reviews, see references 38 -40) . Our findings suggest that part of the effect of a promising antioxidant therapy, which protects heart muscle cells from the acute direct effects of ROS, 41 might be based on the reduction of the mitochondria-induced transcriptional changes that negatively affect cardiomyocyte Ca 2+ signalling. Indeed, NAC has been shown in vivo to improve cardiac function in hypertrophic hearts 42 and decrease the incidence of arrhythmias following infarction, 43 ischaemia, 44 and heart surgery. 45 In addition to reducing markers of oxidative stress in hearts of animal models of cardiomyopathy, 46, 47 NAC has also been implicated in restoring cardiac mitochondrial function in ageing rats. 48 Impaired function of the respiratory chain has been reported in the ageing heart as well as in cardiac pathologies such as myocarditis, arrhythmias, and sudden cardiac death. Our findings suggest that all of these conditions may involve mitochondria-initiated changes in nuclear gene expression as CASQ2 downregulation and subsequent changes in Ca 2+ signalling can be induced by a relatively short period of mitochondrial uncoupling. To what extent these mechanisms contribute to symptoms in mitochondrial diseases is not known, but the results suggest that defective Ca 2+ signalling does not require chronic mitochondrial impairment, but instead can be induced within days. This relates our findings to causes of acute episodes of arrhythmias in cardiac pathologies as well as sudden cardiac death. In summary, we show that, in cardiomyocytes, mitochondrial uncoupling induces changes in Ca 2+ handling which correlated with the decreased expression of the SR Ca 2+ buffer calsequestrin. Uncoupling increases the production of reactive oxygen/nitrogen species, and a reduction in reactive oxygen/nitrogen species by NAC restored the CASQ2 expression, SR Ca 2+ stores, and Ca 2+ signalling of the cells. Collectively, our data suggest that mitochondrial uncoupling results in fast transcriptional changes manifested as compromised Ca 2+ signalling and that these changes can be prevented by ROS scavengers. As impaired mitochondrial function has been implicated in several cardiac pathologies as well as in normal ageing, the mechanisms described here might be involved in a wide spectrum of cardiac conditions.
